Skip to main content

Amcinonide topical Pregnancy and Breastfeeding Warnings

Brand names: Cyclocort

Medically reviewed by Drugs.com. Last updated on Aug 3, 2023.

Amcinonide topical Pregnancy Warnings

This drug should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

US FDA pregnancy category: C

Comments:Topical corticosteroids should not be used extensively on pregnant patients, in large amounts or for extended periods of time.

Animal studies have shown the more potent corticosteroids to be teratogenic after dermal application. There are no adequate and well-controlled studies in pregnant women on the teratogenic effects from topically applied corticosteroids.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Amcinonide topical Breastfeeding Warnings

A decision should be made whether to discontinue breastfeeding or to discontinue the drug, taking into account the importance of the drug to the mother.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

See also

References for pregnancy information

  1. Product Information. Cyclocort (amcinonide topical). Fujisawa. 2001;PROD.

References for breastfeeding information

  1. Product Information. Cyclocort (amcinonide topical). Fujisawa. 2001;PROD.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer